When.com Web Search

  1. Ads

    related to: chf treatment pathway guidelines 2022 chart uscis

Search results

  1. Results From The WOW.Com Content Network
  2. Acute decompensated heart failure - Wikipedia

    en.wikipedia.org/wiki/Acute_decompensated_heart...

    Acute decompensated heart failure (ADHF) is a sudden worsening of the signs and symptoms of heart failure, which typically includes difficulty breathing (dyspnea), leg or feet swelling, and fatigue. [1] ADHF is a common and potentially serious cause of acute respiratory distress. The condition is caused by severe congestion of multiple organs ...

  3. Management of heart failure - Wikipedia

    en.wikipedia.org/wiki/Management_of_heart_failure

    Sleep apnea is an under-recognized risk factor for heart failure. Uncontrolled sleep apnea may increase the risk of heart failure by up to 140%. [3] Weight reduction – through physical activity and dietary modification, as obesity is a risk factor for heart failure and left ventricular hypertrophy. Effective weight management has been shown ...

  4. Heart failure - Wikipedia

    en.wikipedia.org/wiki/Heart_failure

    35% risk of death in first year [ 10 ] Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart 's ability to fill with and pump blood. Although symptoms vary based on which side of the heart is affected, HF typically presents with shortness of breath, excessive fatigue, and bilateral ...

  5. Cardiac contractility modulation - Wikipedia

    en.wikipedia.org/wiki/Cardiac_contractility...

    The FDA approved the OPTIMIZER Smart System, which delivers cardiac contractility modulation therapy, as indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for cardiac resynchronization therapy, and ...

  6. Hypertrophic cardiomyopathy - Wikipedia

    en.wikipedia.org/wiki/Hypertrophic_cardiomyopathy

    Often, symptoms mimic those of congestive heart failure (esp. activity intolerance and dyspnea), but treatment of each is different. Beta blockers are used in both cases, but treatment with diuretics, a mainstay of CHF treatment, will exacerbate symptoms in hypertrophic obstructive cardiomyopathy by decreasing ventricular preload volume and ...

  7. Clinical pathway - Wikipedia

    en.wikipedia.org/wiki/Clinical_pathway

    A clinical pathway is a multidisciplinary management tool based on evidence-based practice for a specific group of patients with a predictable clinical course, in which the different tasks (interventions) by the professionals involved in the patient care are defined, optimized and sequenced either by hour (ED), day (acute care) or visit (homecare).

  8. Tachycardia-induced cardiomyopathy - Wikipedia

    en.wikipedia.org/wiki/Tachycardia-induced_cardio...

    Tachycardia-induced cardiomyopathy (TIC) is a disease where prolonged tachycardia (a fast heart rate) or arrhythmia (an irregular heart rhythm) causes an impairment of the myocardium (heart muscle), which can result in heart failure. [1][5] People with TIC may have symptoms associated with heart failure (e.g. shortness of breath or ankle ...

  9. Cardiac marker - Wikipedia

    en.wikipedia.org/wiki/Cardiac_marker

    Cardiac markers are used for the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome and for management and prognosis in patients with diseases like acute heart failure. Most of the early markers identified were enzymes, and as a result, the term "cardiac enzymes" is sometimes used.

  1. Ad

    related to: chf treatment pathway guidelines 2022 chart uscis